New chemo cocktail aims to stop triple negative breast cancer from returning
Disease control
Ongoing
This Phase 2 trial is testing a combination of two chemotherapy drugs, liposomal doxorubicin and carboplatin, given after surgery to people with early-stage triple negative breast cancer. The goal is to see if this treatment can reduce the risk of the cancer coming back. The stud…
Phase: PHASE2 • Sponsor: Mridula George, MD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC